Clinical trial
Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B…
NCT00277576 · PowderMed, Industry · Completed
Key facts
| NCT number | NCT00277576 |
|---|---|
| Title | Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection |
| Official title | Phase I, Multi-Centre, Randomised, Placebo-Controlled, Dose Escalation Study to Assess Local & Systemic Tolerability of Therapeutic DNA Plasmid pdpSC18 Vaccine Administered by Particle Mediated Epidermal Delivery Using PowderJect ND10 Delivery System in Subjects With Chronic Hepatitis B Infection |
| Lead sponsor | PowderMed, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Biological |
| Interventions | ppdpSC18 administered by PMED |
| Enrollment | 48 |
| Start date | Jan 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Jan 16, 2006 |
| Last update posted | Nov 21, 2008 |
| Countries | Hong Kong, Singapore, Taiwan, Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: